Patent 8637035 was granted and assigned to Academia Sinica on January, 2014 by the United States Patent and Trademark Office.
Provided herein are monoclonal antibodies specific to dengue virus as well as their antigen-binding fragments, and functional variants. Also disclosed are uses thereof for treating or diagnosing dengue virus infection.